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Abstract The three-dimensional structure of a 244-residue,
multivalent, fetuin-binding lectin, SCAfet, isolated from bluebell
(Scilla campanulata) bulbs, has been solved at 3.3 Aî resolution
by molecular replacement using the coordinates of the 119-
residue, mannose-binding lectin, SCAman, also from bluebell
bulbs. Unlike most monocot mannose-binding lectins, such as
Galanthus nivalis agglutinin from snowdrop bulbs, which fold
into a single domain, SCAfet contains two domains with
approximately 55% sequence identity, joined by a linker peptide.
Both domains are made up of a 12-stranded L-prism II fold, with
three putative carbohydrate-binding sites, one on each subdo-
main. SCAfet binds to the complex saccharides of various animal
glycoproteins but not to simple sugars.
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1. Introduction
Two lectins have recently been isolated from bluebell (Scilla
campanulata) bulbs: a mannose-binding lectin, SCAman, and
a fetuin-binding lectin, SCAfet [1]. SCAman is a tetramer
made up of four identical unglycosylated subunits of 13 143
Da, containing 119 amino acid residues and binds speci¢cally
to K(1,3)- and K(1,6)-linked mannopyranosides. SCAfet which
is also not glycosylated forms tetramers of identical 26 224 Da
protomers, with 244 amino acid residues in a single polypep-
tide chain, but unlike SCAman, SCAfet does not bind any
simple sugars [1]. Both SCAman and SCAfet are members
of the superfamily of monocot mannose-binding lectins but
SCAfet, unlike the majority of proteins that have been char-
acterised in this group [2], contains a polypeptide chain that is
folded into two distinct domains, SCAfet-DOM1 and SCAfet-
DOM2, respectively [1].
To date, there have been only a few reports in the literature
of monocot mannose-binding lectins which have been shown
to contain either intact or cleaved two-domain protomers.
Native TULCI from tulip bulbs is a tetramer of four, two-
domain, 28 kDa subunits, which undergoes partial proteoly-
sis, yielding both cleaved and uncleaved protomers [3]. The N-
terminal and C-terminal domains of TULCI have only 20%
sequence identify and show speci¢cities for the monosaccha-
rides, mannose and GalNAc, respectively. Arum maculatum
agglutinin (AMA) is a dimeric lectin made up of two com-
pletely cleaved protomers which share approximately 40% se-
quence identity and probably exhibit a di¡erent speci¢city
towards monosaccharides [4]. Allium sativum agglutinin I
(ASAI) from garlic bulbs is completely cleaved into two man-
nose-binding domains which are highly homologous (85% se-
quence identity) [5]. The structure of the garlic lectin hetero-
dimer, containing two subunits of approximately 11.5 and
12.5 kDa, has recently been determined [6]. Here we present
the ¢rst report of the 3D structure of the novel intact two-
domain lectin, SCAfet, at 3.3 Aî resolution.
2. Materials and methods
SCAfet has been isolated from bluebell bulbs using a fetuin-Sephar-
ose a⁄nity column, cloned from a cDNA library and sequenced, as
described earlier [1].
SCAfet crystals were grown from 70% saturated ammonium sul-
phate, pH 4.8, by the hanging drop vapour di¡usion method, as
previously described [7]. X-ray intensity data were measured at
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Fig. 1. Alignment of the amino acid sequence of Galanthus nivalis
agglutinin (GNA) with those of the Scilla mannose-binding (SCA-
man) and fetuin-binding (SCAfet-DOM1 and SCAfet-DOM2) lec-
tins. Dashes represent deletions and identical residues are boxed.
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Fig. 2. Vacant Fo-Fc electron density in the region of (A) 114 Asn and (B) 129 Tyr of subunit A. The linker peptide 114 Asn-125 Asn, as well
as the residues 126 Ser, 127 Ile, 128 Leu were excluded from the model at this stage of the analysis. (C) Modelling of part of the 11-residue
linker peptide into the di¡erence density. The ¢gures were produced with O [15].
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293K, with V= 0.92 Aî , on station 9.5 at the Synchroton Radiation
Source, Daresbury Laboratory, UK, using a large MAR Research
image plate detector system. A total of 180‡ of X-ray data was col-
lected from two crystals to a resolution of 3.3 Aî . These data were
processed with MOSFLM [8] and scaled using the CCP4 suite of
programmes [9] yielding a 95.3% complete data set. The monoclinic
unit cell parameters re¢ned to a = 277.94 Aî , b = 164.10 Aî , c = 53.60 Aî
and L= 95.38‡, in space group C2, with six SCAfet monomers per
asymmetric unit, including 68.2% solvent. The crystal structure of
SCAfet was determined by the molecular replacement method, using
the programme package AMoRe [10] and the SCAman dimer [11] as a
search model, with data in the resolution range 8^4 Aî . The sequence
of the SCAman monomer shows 48% and 53% sequence identity to
the ¢rst and second domains of SCAfet, respectively [1]. Six clear
solutions to both the rotation and translation function were obtained,
consistent with the Vm value of 3.87 Aî 3 Da31 [12]. Following opti-
misation with the rigid-body re¢nement protocol of AMoRe, all six
solutions had R-factors of 44.0% and correlation coe⁄cients of 52.7%.
The packing function indicated very few close packing contacts. Re-
¢nement of the six monomers within the asymmetrical unit was under-
taken against data in the resolution range 20^3.3 Aî , using the pro-
gram REFMAC [13]. After a round of re¢nement (20 cycles),
corrections to the amino acid sequence of each of the six SCAfet
monomers were made, according to the sequence given in Fig. 1. At
this stage each SCAfet subunit was comprised of two separate poly-
peptide chains corresponding to domains 1 and 2 of the molecule. In
order to form the complete SCAfet monomer, an insert of 11 residues
was modelled into the di¡erence electron density maps to join the two
chains together. Density modi¢ed maps were calculated using DM
[14], which improved the electron density for the linker peptides and
enabled the inserts to be built (Fig. 2) for the SCAfet monomers. NCS
restraints were used throughout the re¢nement except for the ¢nal 50
cycles. Electron density maps (MFoM3MFcM) and (2MFoM3MFcM) were
computed within the resolution range 3.3^20.0 Aî and displayed using
the modelling programme O [15] at various stages during re¢nement.
3. Results and discussion
The ¢nal model of the SCAfet structure contains 10 890
protein atoms with a crystallographic R-factor of 19.0%
(Rfree = 29.3%, the R-factor calculated for 5% of the data
omitted from the re¢nement) for 34 139 re£ections in the res-
olution range 20.0^3.3 Aî .
Our structural studies show that the polypeptide chain of
each SCAfet monomer is 244 amino acid residues long and is
folded into two distinct domains, 1 and 2, joined by a linker
peptide, as illustrated in Fig. 3. Both domains of SCAfet are
composed of three subdomains (I, II and III) related by pseu-
do-three-fold symmetry with each subdomain containing a 4-
stranded antiparallel L-sheet. Thus, each domain consists of a
12-stranded L-prism II fold, similar to that reported in the
other single-domain monocot mannose-binding lectins
[6,11,16^18]. The root mean square deviations for the 244 K
atoms of monomer 1 and the other ¢ve independent mono-
mers were in the range 0.6 to 0.7 Aî .
The 11-residue linker peptide forms a L-turn between the C-
terminal strand of domain 1 and the N-terminal strand of
domain 2 (Fig. 3). As a result of this extra loop, subdomain
I of domain 2 contains an extended L-sheet compared to the
other L-sheets found in the SCAfet monomer.
Superposition of the SCAman dimer (made up of subunits
A and B) onto the SCAfet monomer shows that in subdomain
I of both domains 1 and 2 of SCAfet, there is a shorter loop,
with four amino acid residues deleted, compared with the
same regions of the SCAman monomers. It is clear from an
examination of the 3D structure of SCAfet that the reason for
these shorter loops is to allow for the presence of the 11-res-
idue peptide link which connects domains 1 and 2 (Fig. 4).
SCAfet contains six potential carbohydrate recognition do-
mains per monomer, it associates to form tetramers in solu-
tion so that the functional SCAfet molecule has a total of 24
binding sites. Although SCAfet readily agglutinates trypsin-
treated rabbit erythrocytes, it is inactive towards human er-
ythrocytes from any of the blood groups [1]. Hapten inhibi-
tion assays with SCAfet have shown that none of the mono-
Fig. 3. Stereoview of the three-dimensional backbone fold of the SCAfet monomer showing the two domains, DOM1 and DOM2. The linker
peptide is shown in black. The ¢gure was produced with MOLSCRIPT [19].
Fig. 4. Superposition of SCAman (light gray) onto SCAfet (black)
in the region of subdomain I showing the shorter loop with the
four-residue deletion for SCAfet compared to the corresponding
loop in SCAman and its position relative to the linker peptide. The
¢gure was produced with MOLSCRIPT [19].
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saccharides or oligosaccharides tested had an inhibitory e¡ect
on the agglutination of rabbit erythrocytes [1]. However, as-
says with selected animal glycoproteins revealed that the ag-
glutination activity of SCAfet can be inhibited by asialofetuin,
thyroglobulin, ovomucoid and fetuin suggesting that SCAfet
binds complex N-linked oligosaccharides. The lack of interac-
tion of SCAfet with simple sugars appears to arise as a result
of the replacement of key amino acid residues (Asn, Asp, Gln,
Tyr) within the monosaccharide-binding pocket by hydropho-
bic residues. Molecular docking studies with SCAfet have in-
dicated that only four out of the 24 putative monosaccharide-
binding sites are able to accommodate mannose [1]. Analyses
to determine the precise speci¢city of SCAfet are in progress
and these studies will enable future structural work on carbo-
hydrate complexes of this novel two-domain lectin with an
unusually high number of potential saccharide-binding sites.
The coordinates and structure factors of SCAfet have been
deposited in the PDB with accession code 1DLP.
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